Reporting bias in clinical trials: Progress toward transparency and next steps

Mayookha Mitra-Majumdar; Aaron S Kesselheim

doi:10.1371/journal.pmed.1003894

Reporting bias in clinical trials: Progress toward transparency and next steps

PLoS Med. 2022 Jan 19;19(1):e1003894. doi: 10.1371/journal.pmed.1003894. eCollection 2022 Jan.

Authors

Mayookha Mitra-Majumdar¹, Aaron S Kesselheim¹

Affiliation

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Abstract

Mayookha Mitra-Majumdar and Aaron Kesselheim reflect on steps taken to combat reporting bias in clinical trials over the last two decades.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Bias*
Clinical Trials as Topic / statistics & numerical data*
Humans
Research Design / statistics & numerical data*

Grants and funding

The authors' work was funded by Arnold Ventures (ASK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.